New Pill To Treat Multiple Sclerosis

A new drug for multiple sclerosis can dramatically reduce the chances of a relapse or a deterioration of the condition. The results of a major trial show that taking a course of cladribine tablets just a few times a year can reduce the chances of a relapse by well over 50 per cent. If it becomes available to patients, cladribine will be the first licensed treatment for MS which does not involve regular injections.

Read the whole article on Science Daily

More from Science Daily